Potentiation of neuromuscular transmission by a small molecule calcium channel gating modifier improves motor function in a severe spinal muscular atrophy mouse model
Human Molecular Genetics · 2023
DOI: 10.1093/hmg/ddad019 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, 2023. Verfasst von Kristine S Ojala und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuroscience, Center for Neuroscience, University of Pittsburgh, Pittsburgh, PA 15260, USA. Hauptthemen laut MEDLINE: Activities of Daily Living, Muscular Atrophy, Spinal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Muscular Dystrophy Association, Cure SMA.
Abstract (Originalsprache)
Spinal muscular atrophy (SMA) is a monogenic disease that clinically manifests as severe muscle weakness owing to neurotransmission defects and motoneuron degeneration. Individuals affected by SMA experience neuromuscular weakness that impacts functional activities of daily living. We have used a mouse model of severe SMA (SMNΔ7) to test whether a calcium channel gating modifier (GV-58), alone or in combination with a potassium channel antagonist (3,4-diaminopyridine; 3,4-DAP), can improve neuromuscular function in this mouse model. Bath application of GV-58 alone or in combination with 3,4-DAP significantly restored neuromuscular transmission to control levels in both a mildly vulnerable forearm muscle and a strongly vulnerable trunk muscle in SMNΔ7 mice at postnatal days 10–12. Similarly, acute subcutaneous administration of GV-58 to postnatal day 10 SMNΔ7 mice, alone or in combination with 3,4-DAP, significantly increased a behavioral measure of muscle strength. These data suggest that GV-58 may be a promising treatment candidate that could address deficits in neuromuscular function and strength and that the addition of 3,4-DAP to GV-58 treatment could aid in restoring function in SMA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Neuroscience, Center for Neuroscience, University of Pittsburgh, Pittsburgh, PA 15260, USA.
- Department of Chemistry, University of Pittsburgh, Pittsburgh, PA 15260, USA.
ORCID-Profile: Stephen D Meriney
Förderung
- Muscular Dystrophy Association
- Cure SMA
Zitieren
APA
Ojala, K. S., Kaufhold, C. J., Davey, M. R., Yang, D., Liang, M., Wipf, P., Badawi, Y., & Meriney, S. D. (2023). Potentiation of neuromuscular transmission by a small molecule calcium channel gating modifier improves motor function in a severe spinal muscular atrophy mouse model. Human Molecular Genetics. https://doi.org/10.1093/hmg/ddad019
Vancouver
Ojala KS, Kaufhold CJ, Davey MR, Yang D, Liang M, Wipf P, et al. Potentiation of neuromuscular transmission by a small molecule calcium channel gating modifier improves motor function in a severe spinal muscular atrophy mouse model. Human Molecular Genetics. 2023. doi:10.1093/hmg/ddad019
BibTeX
@article{Ojala2023,
author = {Ojala, Kristine S and Kaufhold, Cassandra J and Davey, Mykenzie R and Yang, Donggyun and Liang, Mary and Wipf, Peter and Badawi, Yomna and Meriney, Stephen D},
title = {Potentiation of neuromuscular transmission by a small molecule calcium channel gating modifier improves motor function in a severe spinal muscular atrophy mouse model},
journal = {Human Molecular Genetics},
year = {2023},
doi = {10.1093/hmg/ddad019}
}
EUVIMED